SynAffix B.V.

Pays‑Bas


Commandez votre montre hebdomadaire SynAffix B.V.
Quantité totale PI 116
Rang # Quantité totale PI 11 609
Note d'activité PI 2,8/5.0    85
Rang # Activité PI 8 026
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

50 7
3 0
43 6
7
 
Dernier brevet 2025 - Antibody-drug conjugates with ma...
Premier brevet 2011 - Fused cyclooctyne compounds and ...
Dernière marque 2025 - SYN-DUO
Première marque 2014 - SYNAFFIX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Reagents and bioactive compounds for industrial and scientific use. Pharmaceuticals for the in v...
P/S Reagents and bioactive compounds, being peptides, proteins, glycans, nucleotides, lipids and chem...
P/S Reagents and bioactive compounds for industrial and scientific use. Pharmaceuticals for the in vi...
Invention Antibody-drug conjugates with masked pbd dimers. The inventions concerns conjugates of masked PB...
Invention Antibody-oligonucleotide conjugates. y1y1 – LDx zz (1), wherein Ab is an antibody, Z is a connect...
Invention Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphate. The current invention...
Invention Method for producing azido-sugars and compounds obtained thereby. The present invention concerns ...
Invention Anthracyclins and conjugates thereof. The invention concerns analogues of nemorubicin as well as...
2024 Invention Modified antibody, antibody-conjugate and process for the preparation thereof. The present inven...
Invention Fused cyclooctyne compounds and their use in metal-free click reactions. The invention relates t...
Invention Antibody-conjugates for targeting of tumours expressing ptk7. 2—; D is selected from the group co...
Invention Antibody-conjugates for targeting of tumours expressing trop-2. The present invention concerns a...
Invention Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigen. The present in...
P/S Reagents and bioactive compounds being cells for industrial and scientific use Chemical analysis,...
P/S Reagents and bioactive compounds for industrial and scientific use. Chemical analysis, research ...
P/S Reagents and bioactive compounds for industrial and scientific use. Chemical and/or enzymatic mod...
Invention Cleavable immune cell engagers. xx containing x reactive moieties F, wherein x is an integer in t...
Invention Stable 4-isoxazoline conjugates. The invention concerns nitrones that are capable of forming 4-is...
Invention Bioconjugates containing sulfamide linkers for use in treatment. The present invention is based ...
Invention Homogeneous antibody-conjugates with high payload loading. The invention concerns homogenous anti...
2023 Invention Antibody-drug conjugates with masked pbd dimers. The inventions concerns conjugates of masked PBD...
Invention Endo-bicyclononene. ZexoendoZendoendoexoZZ-4-ene of structure (1) with a base and an alcohol of f...
Invention Anthracyclins and conjugates thereof. The invention concerns analogues of nemorubicin as well as ...
Invention Glycan-conjugated antibodies binding to fc-gamma receptor. The present invention provides antibo...
Invention Tyrosine-based antibody conjugates. A process for preparing a glycoprotein-conjugate is provided...
Invention Antibody-conjugates for targeting of tumours expressing nectin-4. The present invention concerns...
Invention Antibody-conjugates for targeting of tumours expressing ptk7. 6bxyy (1) Herein, AB is an antibody...
Invention Antibody-conjugates for targeting of tumours expressing trop-2. The present invention concerns an...
Invention Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigen. The present inv...
Invention Antibody-conjugates for targeting of tumours expressing nectin-4. The present invention concerns ...
Invention Antibody-exatecan conjugates. The present invention concerns an antibody-drug conjugate, having ...
Invention Methods for the preparation of bioconjugates. A surfactant for a bioconjugation reaction is disc...
Invention Enediyne conjugates. The invention relates to compounds of general structure (1): Q-(L1)n-(L2)o-...
2022 Invention Methods for the preparation of linker payload constructs. The present invention concerns a metho...
Invention Via cycloaddition bilaterally functionalized antibodies. The present invention provides antibody...
Invention Conjugates of antibodies an immune cell engagers. The present invention concerns a process for p...
Invention Fused cyclooctyne compounds and their use in metal-free click reactions. The invention relates to...
Invention Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for imp...
Invention Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived ...
Invention Multifunctional antibodies. The present invention concerns multifunctional antibody construct co...
Invention Multifunctional antibodies. The present invention concerns multifunctional antibody construct con...
Invention Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphate. The current invention ...
2021 Invention Glycan-conjugated antibodies binding to fc-gamma receptor. berxsyNN-acetylglucosamine moiety; Fuc...
Invention Acetal-based cleavable linkers. The current invention concerns compounds, such as antibody-conju...
Invention Tyrosine-based antibody conjugates. The present invention concerns the finding that that natural ...
Invention Process for the cycloaddition of a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne. ...
Invention Antibody-exatecan conjugates. The present invention concerns an antibody-drug conjugate, having s...
Invention Methods for the preparation of bioconjugates. xxx (3), wherein B is a biomolecule that is functio...
Invention Methods for the preparation of linker payload constructs. The present invention concerns a method...
Invention Antibody-conjugates for targeting of tumours expressing trop-2. wherein AB is an antibody capabl...
Invention Via cycloaddition bilaterally functionalized antibodies. The present invention provides antibody-...
Invention Conjugates of antibodies an immune cell engagers. xx containing x reactive moieties F, wherein x ...
2020 Invention Sulfamide linkers for use in bioconjugates. The invention relates to a novel linker for use in bi...
Invention Enzymes for trimming of glycoproteins. p-EndoY (1), wherein EndoX is an endoglycosidase, EndoY is...
2017 P/S Reagents and bioactive compounds, being peptides, proteins, glycans, nucleotides, lipids and any ...
P/S Medical analysis for the diagnosis and treatment of a condition in patients in the nature of medi...
2016 P/S [ Reagents and bioactive compounds, namely, peptides, proteins, glycans, nucleotides, and lipids ...
P/S Reagents and bioactive compounds, being peptides, proteins, glycans, nucleotides, lipids and any...
2015 P/S [ Reagents and bioactive compounds, being peptides, proteins, glycans, nucleotides, lipids and ch...
2014 P/S [ Reagents for industrial and scientific use; bioactive compounds in the nature of glycoproteins ...
P/S [ Reagents for scientific use; reagents for industrial use, namely, strained cyclooctynes, for th...
P/S Reagents and bioactive compounds for industrial and scientific use. Chemical and/or enzymatic mo...